Latest News and Press Releases

CINCINNATI, OH, Feb. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”) a diversified clinical-stage...

CINCINNATI, OH, Feb. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”), an integrated clinical-stage...

CINCINNATI, OH, Dec. 19, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F3), today announced that President and Chief Executive Officer, James...

CINCINNATI, OH, Sept. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F3), (the “Company” or “Callitas”) announced today with great sadness,...

CINCINNATI, OH, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc., (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development...

CINCINNATI, OH, July 25, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...

CINCINNATI, OH, July 10, 2018 (GLOBE NEWSWIRE) -- Callitas Health Inc. (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”) an integrated clinical-stage pharmaceutical development and...

CINCINNATI, OH & SOUTH ISELIN, NJ, June 26, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical...

CINCINNATI, OH, June 07, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE: LILY, OTCQB: MPHMF, FWB: T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC...

CINCINNATI, OH, June 05, 2018 (GLOBE NEWSWIRE) -- Callitas (CSE:LILY) (OTCQB:MPHMF) (FWB:T3F2), (the “Company” or “Callitas”), an integrated clinical-stage pharmaceutical development and OTC...